Center Book Partners LP Ligand Pharmaceuticals Inc Transaction History
Center Book Partners LP
- $1.42 Billion
- Q1 2025
A detailed history of Center Book Partners LP transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Center Book Partners LP holds 68,299 shares of LGND stock, worth $8.36 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
68,299
Previous 23,539
190.15%
Holding current value
$8.36 Million
Previous $2.52 Million
184.69%
% of portfolio
0.5%
Previous 0.16%
Shares
5 transactions
Others Institutions Holding LGND
# of Institutions
282Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$351 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$252 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$126 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$111 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$91.2 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.07B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...